Feasibility of Neostigmine for Intraoperative Neuromonitoring in Thyroid Surgery

• Status: Not yet recruiting
• Trial end date: 2022-05-02
• Target enrollment: 0
• Participant gender: All

Summary

For successful intraoperative neuromonitoring (IONM), adequate reversal of neuromuscular blocking agent is a prerequisite in thyroid surgery with .

The aim of this study is to investigate the feasibility of neostigmine just after tracheal intubation on the IONM in thyroid surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Collaborator: SMG-SNU Boramae Medical Center
• Treatments: Neostigmine

Criteria

Inclusion Criteria:

• open thyroid surgery with intraoperative neuromonitoring

Exclusion Criteria:

• refusal to participate in the study

• rocuronium should not be used (e.g. renal dysfunction patient)